THE PATH OF LEAST RESISTANCE

12 September 2011

-The lack of financial incentives in comparison to development of medication for chronic diseases is a part of the explanation to why the industry has left this area, but I think there is also a clear scientific challenge here, says Professor Otto Cars of ReAct – Action on Antibiotic Resistance, in the broadcast “As antibiotic resistance increases” on BBC Radio 4 on August 17.

 

- We need to strengthen collaboration between university research and the pharmaceutical industry in a much more open way to really find ways out of this impasse. We need to find a new business model here where the public sector should intervene financially. The product that comes out should not be misused, maybe not even marketed. We cannot have a business model building on sales, for sales will drive misuse and overuse and lead us quicker to resistance, professor Cars says in the interview.

Also participating in the broadcast is Professor Chris Butler, Head of Primary Care and Public Health at Cardiff University , Dr Jennifer Byrne of Queens Medical Centre, Nottingham, Dr David Livermore of the Health Protection Agency and Chief Medical Officer, Dame Sally Davies, Director General of Research and Development and Chief Scientific Adviser for the Department of Health and NHS.

Listen to the broadcast on BBC Radio 4> (30 mins)

Programme  information>

Return | Print